The JAK-STAT pathway may represent a crucial mechanism in this context, as it has been targeted in autoimmune diseases [104] and its role in B-ALL involves the disruption of preleukemic cells differentiation [105]. The gene discussed is SOAT1; the disease is precursor B-cell acute lymphoblastic leukemia.